RVMD:NASDAQ, Revolution Medicines, Inc.

RVMD stock overview

Revolution Medicines, Inc. (RVMD:NASDAQ) closed at $187.14 on October 22, 2026, down 3.68% on the day. The stock trades 16.6% below its 52-week high of $224.31 and 256.6% above its 52-week low of $52.48. Over the past year, it gained 266.7%. Revolution Medicines, Inc. is part of the Health Care sector.

Key figures

Price
$187.14
Day change
-3.68%
Volume
805,449
Average volume
1,986,000
Market cap
40B+
52-week range
$52.48 – $224.31
50-day average
$202.23
200-day average
$153.30

Price action over the past year

In 252 trading sessions since October 21, 2025, RVMD closed higher on 138 days (55%). Its best day was April 13, 2026 (+41.35%) and its worst was January 26, 2026 (-16.87%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

RVMD news

About Revolution Medicines, Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Similar stocks

Find more stocks like RVMD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.